Effectiveness of furosemide in uncontrolled hypertension in the elderly: role of renin profiling.

[1]  G. Schillaci,et al.  [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[2]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[3]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .

[4]  B Neal,et al.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.

[5]  H. Krumholz,et al.  Pulse pressure and risk for myocardial infarction and heart failure in the elderly. , 2000, Journal of the American College of Cardiology.

[6]  M. Glickman,et al.  Inadequate management of blood pressure in a hypertensive population. , 1998, The New England journal of medicine.

[7]  M. Devita,et al.  Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism. , 1998, The Journal of laboratory and clinical medicine.

[8]  J. Webster,et al.  Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. , 1998, Archives of internal medicine.

[9]  J. Laragh,et al.  Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension. , 1998, American journal of hypertension.

[10]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[11]  Detection The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[12]  A. Caggiula,et al.  Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of clinical nutrition.

[13]  M. Epstein,et al.  Aging and the kidney. , 1996, Journal of the American Society of Nephrology : JASN.

[14]  Michael A. Proschan,et al.  Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 1996 .

[15]  R. Glynn,et al.  Evidence for a positive linear relation between blood pressure and mortality in elderly people , 1995, The Lancet.

[16]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[17]  J. Vestbo,et al.  Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. , 1995, Journal of human hypertension.

[18]  J. Laragh Renin profiling for diagnosis, risk assessment, and treatment of hypertension. , 1993, Kidney international.

[19]  J. Neaton,et al.  Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. , 1993, Archives of internal medicine.

[20]  P. A. Zwieten Comparative mechanisms of action of diuretic drugs in hypertension , 1992 .

[21]  J. Chalmers,et al.  Central control of blood pressure. , 1992, European heart journal.

[22]  K. Anastos,et al.  Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. , 1991, Annals of internal medicine.

[23]  K. Kangawa,et al.  High plasma concentrations of human atrial natriuretic polypeptide in aged men. , 1987, The Journal of clinical endocrinology and metabolism.

[24]  G. Reeder,et al.  Atrial natriuretic peptide elevation in congestive heart failure in the human. , 1986, Science.

[25]  C. Bulpitt,et al.  Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial , 1985, The Lancet.

[26]  J. H. Laragh,et al.  Comparison of the effects of diuretic therapy and low sodium intake in isolated systolic hypertension. , 1984, The American journal of medicine.

[27]  J. H. Laragh,et al.  Effects of diuretic therapy in low-, normal- and high-renin isolated systolic systemic hypertension. , 1984, The American journal of cardiology.

[28]  P. Weidmann,et al.  Menopause-dependent plasma lipoprotein alterations in diuretic-treated women. , 1982, Annals of internal medicine.

[29]  Laragh Jh,et al.  Hypertension in the elderly. , 1980 .

[30]  M. N. Lassman,et al.  Age and the renin-aldosterone system. , 1977, Archives of internal medicine.

[31]  Crane Mg,et al.  Effect of aging on renin activity and aldosterone excretion. , 1976 .

[32]  A. H. Norris,et al.  The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. , 1976, Journal of gerontology.

[33]  J. Laragh,et al.  Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. , 1973, The American journal of cardiology.

[34]  J. Laragh Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. , 1973, The American journal of medicine.

[35]  W. Kannel,et al.  Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. , 1971, The American journal of cardiology.